Gore Range Capital
Gore Range Capital, established in 2015 and headquartered in New York, is a venture capital firm specializing in early-stage investments, primarily in the healthcare sector. It focuses on biotechnology, therapeutics, medical devices, and skin health, with a particular emphasis on dermatology and related fields. The firm invests in North America and Western Europe, typically providing $0.5 million to $5 million per venture and taking a lead or co-leading role. Gore Range Capital offers not just capital, but also operational, clinical, and scientific expertise, as well as insights and industry relationships to support its portfolio companies.
Palvella Therapeutics
Post in 2024
Palvella Therapeutics, based in Wayne, Pennsylvania, is a clinical-stage biopharmaceutical company established in 2015. It focuses on developing and commercializing targeted therapies for serious and rare genetic skin diseases, specifically genodermatoses. The company's lead product, QTORIN, is a specialized anhydrous gel designed to deliver active ingredients effectively into the skin, addressing the underlying causes of various dermatological conditions. Palvella's pipeline includes candidates aimed at treating microcystic lymphatic malformations and cutaneous venous malformations, utilizing its proprietary QTORIN platform to offer innovative solutions for underserved patient populations.
Palvella Therapeutics
Series D in 2023
Palvella Therapeutics, based in Wayne, Pennsylvania, is a clinical-stage biopharmaceutical company established in 2015. It focuses on developing and commercializing targeted therapies for serious and rare genetic skin diseases, specifically genodermatoses. The company's lead product, QTORIN, is a specialized anhydrous gel designed to deliver active ingredients effectively into the skin, addressing the underlying causes of various dermatological conditions. Palvella's pipeline includes candidates aimed at treating microcystic lymphatic malformations and cutaneous venous malformations, utilizing its proprietary QTORIN platform to offer innovative solutions for underserved patient populations.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.